Göring, Lukas
Schumann, Sarah
Müller, Jessica
Buck, Andreas K.
Port, Matthias
Lassmann, Michael
Scherthan, Harry
Eberlein, Uta http://orcid.org/0000-0002-2577-3195
Funding for this research was provided by:
Universitätsklinikum Würzburg
Article History
Received: 31 March 2022
Accepted: 30 May 2022
First Online: 27 June 2022
Declarations
:
: The study protocol was presented to the local ethics committee at of the Medical Faculty of the University of Würzburg and approved. All procedures performed in this study involving human participants were in accordance with the ethical standards of the ethics committee (Az. 174/19) and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Michael Lassmann has received research grants by IPSEN Pharma and Nordic Nanovector. All others have no conflicts of interest to declare.